Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Toprak Mahsulleri Ofisi (TMO), or the Turkish Grain Board, is a Turkish state-owned enterprise that plays a critical role in the global pharmaceutical industry through its Afyon Alkaloids Factory. Established in 1938, TMO is the sole authority in Turkey responsible for the regulated cultivation of opium poppies and the extraction of alkaloids. The company's Afyon facility is one of the world's largest producers of morphine and its derivatives, supplying essential active pharmaceutical ingredients (APIs) for pain management and other medical applications. TMO ensures strict compliance with international narcotics control standards while serving as a major supplier to the global pharmaceutical market. Its operations are vital for the legal production of controlled substances used in palliative care and anesthesia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Toprak Mahsulleri Ofisi.